-
Kizdar net |
Kizdar net |
Кыздар Нет
A systematic review and meta-analysis of the efficacy and ... - Nature
Oct 2, 2025 · This systematic review and network meta-analysis evaluated the efficacy and safety of obesity management …
What Long-Term Use of Weight-Loss Drugs Really Shows: A Deep …
A four-year study on weight-loss medications reveals how long-term use affects results, safety, and future obesity treatment. Learn …
GLP-1 Agonists: The Latest Obesity Long-Term Use Data
Jan 26, 2026 · While all three drugs target weight loss by activating GLP-1 receptors, tirzepatide’s dual action on GLP-1 and GIP …
Analysis of the long-term impact of glucagon-like peptide-1 ... - Springer
Sep 30, 2025 · GLP-1 receptor agonist medications are a promising new medical weight loss therapy and have been shown to …
Leading Medical Groups Affirm Obesity Medications Are Safe and ...
Rockville, MD – March 5 — Leading obesity experts have released new guidance confirming that obesity medications are safe, …
Obesity medications: A narrative review of current and emerging agents
Jun 1, 2024 · Compared with lifestyle interventions alone, all medications approved for obesity management are more effective for …
A systematic review and meta-analysis of the efficacy and safety of ...
Apr 24, 2026 · This updated systematic review and network meta-analysis evaluated the efficacy and safety of obesity management …
Beyond weight loss: multisystem benefits of obesity medications
May 28, 2026 · In this Review, we aimed to provide a comprehensive overview of the effects of obesity medications on obesity …
Blockbuster weight loss drugs like Ozempic deliver big results but face ...
Feb 11, 2026 · Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to …
Safety and effects of anti-obesity medications on weight loss ...
Dec 27, 2024 · We conducted a detailed stratified analysis based on individuals living with overweight and obesity, assessing how …
Skip to content
Accessibility Feedback